Cell and Gene Manufacturing and Logistics
-
Exploring Viral And Non-Viral Delivery Methods For Gene Therapy Manufacturing
6/16/2025
Choosing the right delivery system is a critical decision in gene therapy. We explore the advantages and challenges of today’s leading viral and non-viral vector technologies.
-
Enabling Development Of Scalable, Personalized Cell Therapies For Solid Tumor Treatments
6/16/2025
Harnessing the body’s own immune system, researchers are developing personalized cell therapies to target solid tumors, using a patient’s unique mutations to create powerful, individualized treatments.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions
6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
-
Conical Tube Sampling Unit
6/16/2025
Enhance your biopharmaceutical sampling process with compact, centrifuge-ready containers that are designed for flexibility, aseptic transfer, and contamination control at any production stage.
-
Next-Gen Biomanufacturing: Process Intensification For mAb Production
6/13/2025
Intensified processes, omics-driven media, and advanced bioreactors can boost efficiency and scalability in mAb production.
-
A Single Resource For Total Cleanroom Confidence
6/12/2025
Discover innovative, pre-engineered modular cleanroom solutions for the pharmaceutical, biotech, and life science industries with a focus on quality and safety that helps your project meet its requirements.
-
Strategic Logistics: Crafting Scalable Solutions For Maximum Reach And Success
6/12/2025
Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
Proactive Procurement Strategies For Biotech With Tom Wells
6/12/2025
On this week's episode of the Business of Biotech, Tom Wells, Director of Life Sciences at 4C Associates, reveals why -- and how -- smart procurement practices can make or break emerging biotech companies during critical growth stages. Tom shares insights into procurement tools and strategies that can deliver breakthrough solutions, how poor procurement practices can damage investor confidence, and why thinking about procurement as the front end of demand flow, not the back end of supply chain, can help drug developers avoid costly mistakes.
-
Creating A Compliant And Scalable CGT Logistics Launch Plan
6/12/2025
As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.
-
Aseptic Extrusion: Preventing Contamination And Ensuring Product Sterility
6/12/2025
Pharmaceutical extrusion is a key manufacturing process. Discover the critical process considerations and custom engineering required to handle temperature-sensitive and high-viscosity pharmaceutical materials.